Ryan Huang

Ryan Huang is currently a Senior Scientist in the Cell Therapy group at AstraZeneca, where they are developing cell therapy platform technologies. They earned a Doctor of Philosophy in Immunology from UT Southwestern Medical Center, where they also conducted research on treating solid cancers by targeting inhibitory LILRB myeloid cell receptors. Prior to that, Ryan completed a Bachelor of Science in Biochemistry at The University of Texas at Austin and gained research experience as an Undergraduate Research Assistant and a Research Assistant at UT Southwestern Medical Center.